Skip to content
mapperlab
← Dashboard
Stock

INKT

MiNK Therapeutics, Inc.
Latest close $100 of 27 marquee funds currently hold2 CUSIPs mapped
Current holders
0
27 funds tracked
Ever held
2
Current + past
New this quarter
0
Exited this quarter
1

Marquee-fund ownership over time

Aug 9, 2024Nov 14, 2024Nov 13, 2025May 14, 2026
Now
0

This quarter's activity

New positions opened

None.

Positions exited

Past holders

Funds that exited at some point
FundEntry → ExitReturn
Renaissance Technologies 2× in & out→ $11-20%
Millennium Management—+0%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at MiNK Therapeutics, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
6
Filings · last 90d
8
Total on file
124
Recent SEC buffer
Most recent
Jun 5, 2026

30d / 90d windows measured from Jun 5, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 124 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · MiNK Therapeutics, Inc.

Annual figures sourced directly from MiNK Therapeutics, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Net income
-$12.49M
FY2025-16% YoY
EPS (diluted)
$-2.93
FY2025-2% YoY
Free cash flow(?)
-$5.93M
FY2025+38% YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for MiNK Therapeutics, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Renaissance TechnologiesQ4 2025Q2 2026$13$11-20%
Millennium ManagementQ3 2024Q4 2024$0.00—+0%
Renaissance TechnologiesQ3 2024Q2 2025$0.00—+0%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.